SMAD3 and neoplasm: Figure 4, the amount of IFN-γ-producing CD8+ T cells in the tumor tissue remarkably increased in mice receiving Smad3 knockout NK cell therapy compared with that receiving Smad3 wild-type NK therapy, while the increase was reduced by knocking down GM-CSF in Smad3 knockout NK cells.